Central Venous Catheter Lock Solution

NCT ID: NCT00862966

Last Updated: 2009-03-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine whether the application of 47% citrate lock solution decreases the incidence of infection and thrombosis of central venous catheter in hemodialysis population.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bacteremia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

citrate

Group Type EXPERIMENTAL

citrate

Intervention Type OTHER

comparison of different catheter lock solutions

heparin

Group Type ACTIVE_COMPARATOR

heparin

Intervention Type OTHER

comparison of different lock solutions

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

citrate

comparison of different catheter lock solutions

Intervention Type OTHER

heparin

comparison of different lock solutions

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Clinical diagnosis of end stage renal disease

Exclusion Criteria

* Patients refusing randomization
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Medical Center, Tuzla

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Department of Dialysis

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Dialysis

Tuzla, TK, Bosnia and Herzegovina

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Bosnia and Herzegovina

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Goran Imamovic, MD, PhD

Role: CONTACT

+387 61 194 131

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Goran Imamovic, MD,PhD

Role: primary

+387 61 194 131

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UMC-02-139

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Midlines and Thrombophlebitis
NCT03725293 COMPLETED NA